Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1996-07-23
1998-02-24
Rollins, John W.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
5361231, 514 23, 514 25, 514 54, C07G 300, C07H 100
Patent
active
057213453
ABSTRACT:
The invention relates to the use of inulin, oligofructose or their derivatives as functional ingredients in functional food, functional feed, OTC and pharmaceutical composition to prevent mammary carcinogenesis or treat breast cancer.
REFERENCES:
patent: 4927811 (1990-05-01), Quarles
patent: 5169671 (1992-12-01), Harada et al.
The Merck Index, 9th ed. No. 4865, 1976.
Cohen et al; "Modulation of N-Nitrosomethylurea-Induced Mammary Tumor Promotion by Dietary Fiber and Fat"; 1993; pp. 496-501; Journal of the National Cancer Institute.
Cooper et al; "The Anti-Melanoma Activity of Inulin in Mice"; 1986;pp.903-908; Molecular Immunology vol. 23, No. 8.
Fishbein et al; "Fructooligosaccharides: A Review"; 1988; pp. 104-107; Vet Hum Toxicol vol. 30, No. 2, Apr.
Coussement Paul
Delzenne Nathalie
Roberfroid Marcel
Van Loo Jan
Raffinerie Tirlemontoise S.A.
Rollins John W.
LandOfFree
Prevention of mammary carcinogenesis and breast cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of mammary carcinogenesis and breast cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of mammary carcinogenesis and breast cancer treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1876098